Plasma cell-free DNA and its DNA integrity as biomarker to distinguish prostate cancer from benign prostatic hyperplasia in patients with increased serum prostate-specific antigen

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Serum Free Circulating DNA Is a Useful Biomarker to Distinguish Benign versus Malignant Prostate Disease

(2010) E. Gordian et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

The correlation of extent and grade of inflammation with serum PSA levels in patients with IV prostatitis

(2010) LI Gui-zhong et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Efficacy of circulating plasma DNA as a diagnostic tool for advanced non-small cell lung cancer and its predictive utility for survival and response to chemotherapy

(2010) Sachin Kumar et al.   LUNG CANCER

Prostate cancer screening: current status and future perspectives

(2010) Seth A. Strope et al.   Nature Reviews Urology

Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer

(2009) E A M Heijnsdijk et al.   BRITISH JOURNAL OF CANCER

Cell-free Tumor DNA in Blood Plasma As a Marker for Circulating Tumor Cells in Prostate Cancer

(2009) H. Schwarzenbach et al.   CLINICAL CANCER RESEARCH

Investigative clinical study on prostate cancer: on the role of the pretreatment total PSA to free testosterone ratio in selecting different biology groups of prostate cancer patients

(2009) Antonio B. Porcaro et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Prediction of Clear Cell Renal Cell Carcinoma by Integrity of Cell-free DNA in Serum

(2009) Feng Gang et al.   UROLOGY

Diagnostic Role of Circulating Free Plasma DNA Detection in Patients With Localized Prostate Cancer

(2008) Annalisa Altimari et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Cell-Free Circulating DNA: Diagnostic Value in Patients With Testicular Germ Cell Cancer

(2008) Jörg Ellinger et al.   JOURNAL OF UROLOGY

EAU Guidelines on Prostate Cancer

(2007) Axel Heidenreich et al.   EUROPEAN UROLOGY